Millipore Sigma Vibrant Logo

538120 NLRP3 Inhibitor, MCC950 - CAS 256373-96-3 - Calbiochem

A cell-potent, bioavailable NLRP3 inflammasome activation inhibitor. Effectively blocks caspase-1 & -11 activation, IL-1β processing and IL-1β & IL-6 secretion.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: N-(1,2,3,5,6,7-Hexahydro-s-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide, Sodium, MCC-950, MCC950, Cytokine Release Inhibitory Drug 3, CRID 3, CP-456,773

Primary Target: NLRP3
View Products on Sigmaaldrich.com
538120
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
256373-96-3C₂₀H₂₃N₂O₅S·Na

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
5381200001
Retrieving availability...
—
Fulfillment and delivery delayed Fulfillment and delivery delayed
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Glass bottle 10 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewA cell-permeable, bioavailable, non-toxic sulfonylurea derived compound that selectively interacts with NLRP3 inflammasome and prevents its activation in a reversible manner with no effect on NLRC4 and NLRP1. Dose-dependently reduces IL-1β production (IC50 = 7.5 & 8.1 nM in LPS & ATP-treated BMDMs & HMDMs, respectively) with minimal effect on IL-1α & TNF-α. Specifically blocks NLRP3-dependent pyroptotic cell death by inhibiting caspase-1 &-11 activation, IL-1β processing and ASC oligomerization. Does neither block K+ efflux, Ca2+ flux or NLRP3-ASC interactions nor inhibit NLRC4, AIM2, TLR signaling or NLRP3 priming. Effectively suppresses T cell responses and IL-1β & IL-6 secretion, and reduces the severity of EAE and rescues neonatal lethality in a mouse model of CAPS (10 mg/kg, i.p., q.d. & 20 mg/kg, i.p., every other day, respectively). Displays attractive PK profile with desirable microsomal stability and minimal liability towards CYP450 isozymes (< 15% inhibition at 10 µM) & hERG (IC50 > 30 µM).

      Please note that the molecular weight for this compound is batch-specific due to variable water content. Please refer to the vial label or the certificate of analysis for the batch-specific molecular weight. The molecular weight provided represents the baseline molecular weight without water.
      Catalogue Number538120
      Brand Family Calbiochem®
      SynonymsN-(1,2,3,5,6,7-Hexahydro-s-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide, Sodium, MCC-950, MCC950, Cytokine Release Inhibitory Drug 3, CRID 3, CP-456,773
      DescriptionNLRP3 Inhibitor, MCC950
      References
      ReferencesColl, R.C., et al. 2015. Nat. Med. 21, 248.
      Coll, R.C. and O'Neill, L.A.J. 2011. PLoS ONE. 6, e29539.
      Laliberte, R.E., et al. 2003. J. Biol. Chem. 278, 16567.
      Perregaux, D.G., et al. 2001. J. Pharmacol. Exp. Ther. 299, 187.
      Product Information
      CAS number256373-96-3
      FormWhite powder
      FormulationSupplied as a sodium salt.
      Hill FormulaC₂₀H₂₃N₂O₅S·Na
      Chemical formulaC₂₀H₂₃N₂O₅S·Na
      Hygroscopic Hygroscopic
      ReversibleY
      Quality SegmentMQ100
      Applications
      Biological Information
      Primary TargetNLRP3
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade ITEM Number
      Catalogue Number GTIN
      5381200001 04054839059308

      Documentation

      NLRP3 Inhibitor, MCC950 - CAS 256373-96-3 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      NLRP3 Inhibitor, MCC950 - CAS 256373-96-3 - Calbiochem Certificates of Analysis

      TitleLot Number
      538120

      References

      Reference overview
      Coll, R.C., et al. 2015. Nat. Med. 21, 248.
      Coll, R.C. and O'Neill, L.A.J. 2011. PLoS ONE. 6, e29539.
      Laliberte, R.E., et al. 2003. J. Biol. Chem. 278, 16567.
      Perregaux, D.G., et al. 2001. J. Pharmacol. Exp. Ther. 299, 187.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision25-June-2016 JSW
      SynonymsN-(1,2,3,5,6,7-Hexahydro-s-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide, Sodium, MCC-950, MCC950, Cytokine Release Inhibitory Drug 3, CRID 3, CP-456,773
      DescriptionA cell-permeable, bioavailable, non-toxic sulfonylurea derived compound that selectively interacts with NLRP3 inflammasome and prevents its activation in a reversible manner with no effect on NLRC4 and NLRP1. Dose-dependently reduces IL-1β production (IC50 = 7.5 & 8.1 nM in LPS & ATP-treated BMDMs & HMDMs, respectively) with minimal effect on IL-1α & TNF-α. Specifically blocks NLRP3-dependent pyroptotic cell death by inhibiting caspase-1 &-11 activation, IL-1β processing and ASC oligomerization. Does neither block K+ efflux, Ca2+ flux or NLRP3-ASC interactions nor inhibit NLRC4, AIM2, TLR signaling or NLRP3 priming. Effectively suppresses T cell responses and IL-1β & IL-6 secretion, and reduces the severity of EAE and rescues neonatal lethality in a mouse model of CAPS (10 mg/kg, i.p., q.d. & 20 mg/kg, i.p., every other day, respectively). Displays attractive PK profile with desirable microsomal stability and minimal liability towards CYP450 isozymes (< 15% inhibition at 10 µM) & hERG (IC50 > 30 µM).
      FormWhite powder
      FormulationSupplied as a sodium salt.
      Intert gas (Yes/No) Packaged under inert gas
      CAS number256373-96-3
      Chemical formulaC₂₀H₂₃N₂O₅S·Na
      Purity≥97% by HPLC
      SolubilityDMSO (50 mg/ml) or H₂O (1 mg/ml)
      Storage Protect from light
      -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesColl, R.C., et al. 2015. Nat. Med. 21, 248.
      Coll, R.C. and O'Neill, L.A.J. 2011. PLoS ONE. 6, e29539.
      Laliberte, R.E., et al. 2003. J. Biol. Chem. 278, 16567.
      Perregaux, D.G., et al. 2001. J. Pharmacol. Exp. Ther. 299, 187.